TuisAMBI • NYSEAMERICAN
add
Ambipar Emergency Response
Vorige sluiting
$0,43
Dagwisseling
$0,36 - $0,42
Jaarwisseling
$0,20 - $0,55
Markkapitalisasie
23,01 m USD
Gemiddelde volume
5,39 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NYSEAMERICAN
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (BRL) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 817,26 m | 10,36% |
Bedryfskoste | -21,56 m | -262,28% |
Netto inkomste | -99,58 m | -226,98% |
Netto winsgrens | -12,18 | -196,35% |
Wins per aandeel | — | — |
EBITDA | 138,17 m | -17,75% |
Effektiewe belastingkoers | -34,76% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (BRL) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 358,43 m | -15,32% |
Totale bates | 5,80 mjd | 34,60% |
Totale aanspreeklikheid | 3,98 mjd | 34,93% |
Totale ekwiteit | 1,82 mjd | — |
Uitstaande aandele | 55,43 m | — |
Prys om te bespreek | 0,02 | — |
Opbrengs op bates | 3,94% | — |
Opbrengs op kapitaal | 4,63% | — |
Kontantvloei
Netto kontantverandering
| (BRL) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -99,58 m | -226,98% |
Kontant van bedrywe | 110,44 m | 35,69% |
Kontant van beleggings | 77,48 m | 184,48% |
Kontant van finansiering | -381,16 m | -157,73% |
Netto kontantverandering | -82,47 m | 5,91% |
Beskikbare kontantvloei | -260,36 m | -2 494,33% |
Meer oor
Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases. As of March 2014, the company was based in San Diego, California, and consisted of a single facility. Ambit made an initial public offering in May 2013, and was listed on the NASDAQ exchange under the symbol "AMBI". Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange. Wikipedia
Gestig
01 Jan. 2000
Webwerf
Werknemers
53
